Tempus AI Has 25% Float Short: ARK's $11M Bet Sets Up a Squeeze
ARK Invest's $11.2mn pre-earnings TEM purchase collides with Sumitomo Mitsui's stake reduction, setting up a high-stakes catalyst event where 24.9% short interest amplifies the downside or squeeze ris
Tempus AI Has 25% Float Short: ARK's $11M Bet Sets Up a Squeeze
NEW YORK, November 1 —
Tempus AI, Inc. (TEM) enters earnings with 24.9% of its float sold short and ARK Invest freshly committed $11.2mn to the other side.
- TTM revenue of $1.4bn growing 21.6% YoY; full-year guidance update is the decisive print
- Forward P/E of -1556.8x and trailing EPS of $-1.44 mean TEM is priced entirely on narrative, not earnings
- Earnings due imminently; any positive surprise hits 24.9% short interest as a mechanical forcing function
The Short Interest Is the Actual Trade Setup
Nearly one in four TEM shares in the float is a bet against the stock. That is the mechanical fact that matters more than any single guidance line on the call. If revenue accelerates or management raises the full-year outlook, short sellers face covering pressure that amplifies the move well beyond the headline beat. The inverse holds with equal force: a miss into 24.9% short interest does not need to be large to turn ugly fast.
Cathie Wood's $11.2mn ARK purchase ahead of the print is not quiet accumulation. It is a position built explicitly into a catalyst window, where squeeze mechanics, not fundamental re-rating, drive the near-term return. ARK is not making a slow-money call on AI healthcare data; it is making a fast-money call on timing.
Sumitomo's Exit Carries a Different Signal
Sumitomo Mitsui Trust Group reduced its TEM stake in the same stretch ARK was adding. That institutional divergence is worth more than a headline. Sumitomo is one of Japan's largest asset managers, and its risk framework leans conservative. When a patient institutional holder trims ahead of a binary catalyst, the message is usually about downside asymmetry, not a philosophical disagreement about AI's future in oncology diagnostics.
The numbers justify the caution. Trailing EPS stands at $-1.44. FCF is $-99mn. A forward P/E of -1556.8x is not a valuation multiple in any conventional sense. It is an acknowledgment that TEM is not being priced on earnings at all. At $72.22, the stock is a pure story multiple, and story multiples punish misses disproportionately when growth fails to compensate.
21.6% Revenue Growth Is the Floor, Not the Catalyst
TTM revenue of $1.4bn at 21.6% YoY growth is a serviceable number, not exceptional for a stock at this multiple. In a sector that prices acceleration, flat guidance reads as deceleration, and deceleration into $-99mn FCF is exactly the configuration that validates the short thesis. The watch metric on the call is not whether TEM beats the quarter. It is whether management signals a credible path toward positive cash flow, or at minimum, raises the full-year revenue target in a way that justifies the current price.
The bull case collapses if guidance is flat or below expectations, stranding the -1556.8x fwd P/E with no growth rate to lean on. The bear case collapses if revenue growth accelerates above current YoY pace and the FCF burn narrows QoQ. Either outcome through that short base will move fast.
Generate a complete fundamental breakdown at /stock/tem, or pressure-test TEM's implied growth assumptions with the DCF calculator.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Tempus AI (TEM) earnings are imminent, with analysts and investors debating whether the stock will rally or sell off on results.